Skip to NavigationSkip to content

Pharmafile - Medical Communications

Eisai has revealed that its multireceptor Tyrosine Kinase Inhibitor Lenvima (lenvatinib) has been recommended by NICE, meaning it can now be used...
Check out this week’s top ten most popular stories on Pharmafile.com!
Britain’s cost effectiveness body the National Institute of Health and Care Excellence (NICE) has chosen not to recommend AstraZeneca’s Olaparib...
The NHS in England is now spending over £1billion a year on diabetes prescriptions, almost doubling in the last decade, according to NHS Digital.

Features

“Don’t conform to what people want – take risks. The people who make a big difference are the ones who take risks in uncertain times”

Appointments

American antiviral drug specialist Gilead have appointed Pfizer and AbbVie veteran Michael Boyd as VP of government affairs and policy strategies...

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches